Search research articles
Contact Us
Filters
Showing results (51-60 of 115) with videos related to
Page
of 12
Sort By:
Journal of Proteome Research
|
January 11, 2011
Analysis of phosphotyrosine signaling in glioblastoma identifies STAT5 as a novel downstream target of ΔEGFR
Vaibhav Chumbalkar, Khatri Latha, YeoHyeon Hwang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2007
The efficacy of epidermal growth factor receptor-specific antibodies against glioma xenografts is influenced by receptor levels, activation status, and heterodimerization
Terrance G Johns, Rushika M Perera, Sonja C Vernes, et al.
International Journal of Cancer
|
June 26, 2012
Nuclear EGFRvIII-STAT5b complex contributes to glioblastoma cell survival by direct activation of the Bcl-XL promoter
Khatri Latha, Ming Li, Vaibhav Chumbalkar, et al.
Cancers
|
May 11, 2024
Integration of Computational Pipeline to Streamline Efficacious Drug Nomination and Biomarker Discovery in Glioblastoma
Danielle Maeser, Robert F Gruener, Robert Galvin, et al.
Biorxiv : the Preprint Server for Biology
|
May 7, 2024
Droplet Hi-C for Fast and Scalable Profiling of Chromatin Architecture in Single Cells
Lei Chang, Yang Xie, Brett Taylor, et al.
Oncogene
|
December 6, 2011
EGFRvIII promotes glioma angiogenesis and growth through the NF-κB, interleukin-8 pathway
R Bonavia, M M Inda, S Vandenberg, et al.
Cancer Research
|
January 18, 2014
Suppression of microRNA-9 by mutant EGFR signaling upregulates FOXP1 to enhance glioblastoma tumorigenicity
German G Gomez, Stefano Volinia, Carlo M Croce, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 5, 1998
In vitro loss of heterozygosity targets the PTEN/MMAC1 gene in melanoma
G P Robertson, F B Furnari, M E Miele, et al.
Molecular Biosystems
|
May 13, 2010
Phosphotyrosine signaling analysis of site-specific mutations on EGFRvIII identifies determinants governing glioblastoma cell growth
Paul H Huang, Emily R Miraldi, Alexander M Xu, et al.
Neuro-Oncology
|
September 20, 2022
EGFR, the Lazarus target for precision oncology in glioblastoma
Benjamin Lin, Julia Ziebro, Erin Smithberger, et al.
Page
of 12
Search research articles
Search
Showing results (51-60 of 115) with videos related to
Sort By:
Page
of 12
Journal of Proteome Research
|
January 11, 2011
Analysis of phosphotyrosine signaling in glioblastoma identifies STAT5 as a novel downstream target of ΔEGFR
Vaibhav Chumbalkar, Khatri Latha, YeoHyeon Hwang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 17, 2007
The efficacy of epidermal growth factor receptor-specific antibodies against glioma xenografts is influenced by receptor levels, activation status, and heterodimerization
Terrance G Johns, Rushika M Perera, Sonja C Vernes, et al.
International Journal of Cancer
|
June 26, 2012
Nuclear EGFRvIII-STAT5b complex contributes to glioblastoma cell survival by direct activation of the Bcl-XL promoter
Khatri Latha, Ming Li, Vaibhav Chumbalkar, et al.
Cancers
|
May 11, 2024
Integration of Computational Pipeline to Streamline Efficacious Drug Nomination and Biomarker Discovery in Glioblastoma
Danielle Maeser, Robert F Gruener, Robert Galvin, et al.
Biorxiv : the Preprint Server for Biology
|
May 7, 2024
Droplet Hi-C for Fast and Scalable Profiling of Chromatin Architecture in Single Cells
Lei Chang, Yang Xie, Brett Taylor, et al.
Oncogene
|
December 6, 2011
EGFRvIII promotes glioma angiogenesis and growth through the NF-κB, interleukin-8 pathway
R Bonavia, M M Inda, S Vandenberg, et al.
Cancer Research
|
January 18, 2014
Suppression of microRNA-9 by mutant EGFR signaling upregulates FOXP1 to enhance glioblastoma tumorigenicity
German G Gomez, Stefano Volinia, Carlo M Croce, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 5, 1998
In vitro loss of heterozygosity targets the PTEN/MMAC1 gene in melanoma
G P Robertson, F B Furnari, M E Miele, et al.
Molecular Biosystems
|
May 13, 2010
Phosphotyrosine signaling analysis of site-specific mutations on EGFRvIII identifies determinants governing glioblastoma cell growth
Paul H Huang, Emily R Miraldi, Alexander M Xu, et al.
Neuro-Oncology
|
September 20, 2022
EGFR, the Lazarus target for precision oncology in glioblastoma
Benjamin Lin, Julia Ziebro, Erin Smithberger, et al.
Page
of 12